Breakthrough antibody therapy targets Alzheimer’s risk gene, offers hope for effective treatment Post author: Post published:October 6, 2023 Post category:uncategorized Researchers introduced and characterized a novel platform based on monoclonal antibodies (mAbs). You Might Also Like Genetic insights reveal new targets for treating extracranial arteriovenous malformations July 10, 2025 Researchers receive CAD 45 million to study new psychosis treatments November 6, 2024 How parental stress and long work weeks shape children’s reading outcomes November 12, 2025
Genetic insights reveal new targets for treating extracranial arteriovenous malformations July 10, 2025